Isomorphic Labs says it raised $5 billion; Hassabis has stepped down as Google DeepMind CEO for three and a half months
Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
AI summary
AI drug discovery company Isomorphic Labs, founded by Demis Hassabis, has completed a $5 billion Series C funding round. The round was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and Alphabet; the funds will be used to design and develop new drugs with AI. According to Dealroom, drug discovery startups raised a record $23.2 billion in 2026.